Healthy volunteers needed to help improve cancer care
NCT ID NCT07305753
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to collect body composition data from 40 healthy adults to develop better measurement methods for cancer patients. Participants will undergo tests like sodium bromide and deuterium dilution to measure muscle mass and body water. The study does not involve any treatment or medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
May 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The participants will be community dwelling, have a self-reported ability to walk one-quarter of a mile and climb 10 steps without difficulty, self-reported ability to perform activities of daily living (ADLs) without difficulty, and no life-threatening conditions or diseases that would alter their body composition from what is typical for their age, sex, and BMI. Overall, participants must be ambulatory, able to withstand lying flat on the DXA table for up to 10 minutes, stand without aid for 2 minutes, weigh less than 440 lbs and be in generally good health.
- Ages
-
20 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being either male or female * Being an adult \>20 - \<40 or \>70 years of age. * Having a body weight of less than 440 pounds * Being willing to comply with the study procedures * Not having a chronic illness (e.g., diabetes, cancer, etc.) * Must be willing to have biospecimens and imaging stored for research use Exclusion Criteria: * Being pregnant, attempting to become pregnant, or breastfeeding * Having medical implants such as a pacemaker or metal joint replacements * Having had a mastectomy, breast reduction, or breast implants * Having hair that cannot fit in a swim cap * Having a body weight greater than 440 pounds * Taking medications that alter the body's fluid compartments (ex: diuretics) * Not willing to have biospecimens and imaging stored for future research use.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Elderly (people aged 65 or more) are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Pennington Biomedical Research Center
RECRUITINGBaton Rouge, Louisiana, 70808, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does it matter where you inject? scientists test Weight-Loss drug in arm, thigh, and belly
- Can sharing life stories restore dignity in care homes?
- New drug RO7830698 put to the test for COPD
- Three pill versions of one drug go head to head in the bloodstream
- Pfizer tests RSV vaccine aimed at older adults
- Radioactive tracer maps where a new drug goes in the body